1-苄氧基-3-氟苯 | 72216-35-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-苄氧基-3-氟苯
• 英文名称: 1-(benzyloxy)-3-fluorobenzene
• 英文别名: 1-fluoro-3-phenylmethoxybenzene
• CAS: 72216-35-4
• 化学式: C₁₃H₁₁FO
• mdl: MFCD06409983
• 分子量: 202.228
• InChiKey: DIQOSFBOCFVINE-UHFFFAOYSA-N

物化性质

• 熔点：
  32-34°C
• 沸点：
  185°C
• 闪点：
  68°C

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2909309090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Benzyloxy-3-fluorobenzene
Synonyms: 1-(Benzyloxy)-3-fluorobenzene

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Benzyloxy-3-fluorobenzene
CAS number: 72216-35-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H11FO
Molecular weight: 202.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-苄氧基-3-氟苯 在 potassium tert-butylate 、 二苯基膦 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 以90%的产率得到3-氟苯酚
  参考文献：
  名称：

  用 HPPh2 和 tBuOK 对芳基甲基/苄基/烯丙基醚进行脱保护的温和实用方法

  摘要：

  报道了使用 HPPh 2和t BuOK 对芳基醚进行去甲基化、去苄基化和去烯丙基化的通用方法。该反应具有温和且不含金属的反应条件、广泛的底物范围、良好的官能团相容性以及对芳基醚的化学选择性高于脂肪族结构。值得注意的是，这种方法能够选择性地去保护烯丙基或苄基，使其成为有机合成中通用且实用的方法。

  DOI：

  10.1039/d1ob01286j
• 作为产物：
  描述：

  3-(苄氧基)苯基三氟甲磺酸酯 在 bis[chloro(1,2,3-trihapto-allylbenzene)palladium(II)] 、 2-二叔丁基膦-2′,4′,6′-三异丙基-3,6-二甲氧基-1,1′-联苯 、 cesium fluoride 作用下， 以 环己烷 为溶剂， 反应 12.0h， 以57%的产率得到1-苄氧基-3-氟苯
  参考文献：
  名称：

  从 LPdAr(F) 形成 ArF：芳基三氟甲磺酸酯催化转化为芳基氟化物

  摘要：

  容易氟化 氟原子已成为药物中有用的取代基。然而，合成引入它们仍然具有挑战性，因为目前形成碳氟键的方法需要腐蚀性条件或有些奇特的、因此昂贵的试剂。一个症结是传统钯催化剂未能将芳基与配位氟化物偶联。沃森等人。（第 1661 页，8 月 13 日在线发表；参见 Gouverneur 的 Perspective）表明，将钯与精心设计的膦配体配对可使用简单的氟化物盐产生用于芳基氟化的多功能催化剂。该方法可耐受一系列官能团，并应促进多种含氟芳烃目标的有效合成。催化剂能够使用简单的氟化物盐形成多功能的碳氟键。尽管药物重要性日益增加，但氟化芳族有机分子仍然难以合成。目前的方法需要苛刻的反应条件或高度专业化的试剂，使得复杂氟芳烃的制备具有挑战性。因此，开发克服目前使用的这些技术的局限性的通用制备方法是非常有意义的。我们制备了 [LPd(II)Ar(F)] 配合物，其中 L 是联芳单膦配体，Ar 是芳基，并确定了发生还原消除以形成

  DOI：

  10.1126/science.1178239
• 作为试剂：
  描述：

  镁 、 1-苄氧基-3-氟苯 、 N,N-二甲基甲酰胺 在 1-苄氧基-3-氟苯 四氢呋喃 、 乙酸乙酯 、 水 、 盐酸 、 碳酸氢钠 、 Brine 、 Sodium sulfate-III 、 resultant residue 、 ethyl acetate n-hexane 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以to provide 77.3 g of 2-benzyloxy-4-fluorobenzaldehyde的产率得到2-(苄氧基)-4-氟苯甲醛
  参考文献：
  名称：

  Substituted biphenyls

  摘要：

  具有葡萄糖高原素受体拮抗活性的取代联苯。所述化合物的公式为其中R1a和R1b独立地表示（C1-C6）烷基；R2表示（C1-C10）烷基或取代的（C1-C10）烷基，其中取代基独立地为1-3个- SR7; R7表示苯基或取代的苯基，其中取代基独立地为1-5个卤素，三氟甲基，（C1-C6）烷基，（C1-C6）烷氧基，硝基，氰基或羟基；R3表示取代的（C1-C6）烷基，其中取代基为1-2个羟基；G表示从卤素，（C1-C6）烷基和OR4中选择的取代基，其中R4为H或（C1-C6）烷基；y为0或1-3的整数。还声明了包含这些化合物的药物组合物以及通过给予这些化合物进行治疗葡萄糖高原素介导的疾病的方法。

  公开号：

  US06218431B1

文献信息

• [EN] METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS<br/>[FR] PROCEDES DE TRAITEMENT D'AMYLOIDOSE UTILISANT DES INHIBITEURS DE PROTEASE ASPARTYLE
  申请人：ELAN PHARM INC

  公开号：WO2005070407A1

  公开（公告）日：2005-08-04

  The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

  这项发明涉及乙酰2-羟基-1,3-二氨基螺环己烷及其衍生物，可用于治疗与淀粉样变性相关的疾病、疾病和症状。淀粉样变性是指与A-beta蛋白异常沉积相关的一系列疾病、疾病和症状。
• Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors
  申请人：John Varghese

  公开号：US20060014737A1

  公开（公告）日：2006-01-19

  The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

  这项发明涉及新型化合物和治疗与淀粉样变性相关的疾病、紊乱和症状的方法。淀粉样变性指与A-beta蛋白异常沉积相关的一系列疾病、紊乱和症状。
• Novel compounds useful for bradykinin B1 receptor antagonism
  申请人：Tung S. Jay

  公开号：US20060217362A1

  公开（公告）日：2006-09-28

  Disclosed are compounds that are bradykinin B 1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B 1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.

  揭示了一些化合物，它们是激肽酶B1受体拮抗剂，可用于治疗哺乳动物中由激肽酶B1受体介导的疾病，或缓解与疾病状况相关的不良症状。其中某些化合物表现出增强的效力，并且预计还将表现出延长的作用持续时间。
• Fluorinated Radicamine A and B: Synthesis and Glycosidase Inhibition
  作者：Yi-Xian Li、Ren Iwaki、Atsushi Kato、Yue-Mei Jia、George W. J. Fleet、Xuan Zhao、Min Xiao、Chu-Yi Yu

  DOI：10.1002/ejoc.201501453

  日期：2016.3

  Fluorinated derivatives of radicamine A and radicamine B have been synthesized from D-arabinose-derived cyclic nitrone. Structure–activity relationship studies showed that glycosidase inhibition of these fluorinated derivatives was significantly influenced by the position of the fluorine atom. C-7 or C-11 fluorination of the aromatic ring decreased α-glucosidase inhibition of the derivatives, whereas

  已经从 D-阿拉伯糖衍生的环硝酮合成了 radicamine A 和 radicamine B 的氟化衍生物。构效关系研究表明，这些氟化衍生物的糖苷酶抑制受到氟原子位置的显着影响。芳环的 C-7 或 C-11 氟化降低了衍生物对 α-葡萄糖苷酶的抑制作用，而 C-8 或 C-10 氟化保留了糖苷酶抑制活性。
• [EN] SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS<br/>[FR] UREE ET CARBAMATE SUBSTITUES, PHENACYL-2-HYDROXY-3-DIAMINOALCANE, ET BENZAMIDE-2-HYDROXY-3-DIAMINOALCANE INHIBITEURS D'ASPARTYL-PROTEASE
  申请人：ELAN PHARM INC

  公开号：WO2005087215A1

  公开（公告）日：2005-09-22

  The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.

  这项发明涉及乙酰2-羟基-1,3-二氨基螺环己烷及其衍生物，可用于治疗与淀粉样变性相关的至少一种疾病、紊乱和病况。淀粉样变性指与A-beta蛋白异常沉积相关的一系列疾病、紊乱和病况。